Blueprint Medicines Corporation (LON:0HOJ)

Blueprint Medicines Revenue

In the year 2024, Blueprint Medicines had annual revenue of $508.82M USD with 104.04% growth. Blueprint Medicines had revenue of $146.37M in the quarter ending December 31, 2024, with 103.41% growth.

• Revenue: $508.82M
• Revenue Growth: +104.04%
• P/S Ratio: 10.16
• Revenue / Employee: $784.01K
• Employees: 649
• Market Cap: 4.13B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	508.82M	259.44M	104.04%
Dec 31, 2023	249.38M	45.34M	22.22%
Dec 31, 2022	204.04M	23.96M	13.30%
Dec 31, 2021	180.08M	-613.66M	-77.31%
Dec 31, 2020	793.74M	727.22M	1,093.37%